Back to Search
DANIEL MICHELSON, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1144072307Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD.
PMID 17242628·J Am Acad Child Adolesc Psychiatry·2007
8-other
High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses.
PMID 17712236·J Am Acad Child Adolesc Psychiatry·2007
2-rct
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.
PMID 17474814·J Clin Psychiatry·2007
4-observational
Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.
PMID 15213591·J Am Acad Child Adolesc Psychiatry·2004
3-trial
Tethered cord syndrome in childhood: diagnostic features and relationship to congenital anomalies.
PMID 15494116·Neurol Res·2004
6-review
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.
PMID 12547466·Biol Psychiatry·2003
3-trial
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.
PMID 12411225·Am J Psychiatry·2002
3-trial
Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trial.
PMID 11731354·Br J Psychiatry·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1010 4TH ST SW, SUITE 340
MASON CITY, IA 50401 - Phone
- (641) 428-7766
Quick Facts
- NPI
- 1144072307
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile